Skip to main content

Table 5 Summary table of literature analysis, PICOT question 3: influence of smoking on asthma outcomes in patients receiving ICS therapy

From: Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force

Reference

Statement

Type of data source

Final level of evidence (see Fig. 1)

Possible impact on clinical practice (TF opinion)

Similar evidence available from RCTs

Brusselle et al. [33]

Lower asthma control in smokers but same treatment benefit irrespective of smoking status

PC

Low (see text)

No

No

Roche et al. [65]

Better outcomes with extra-fine versus standard size particle ICS, larger differences in current and ex-smokers

D-M-A

Moderate

Uncertain (exploratory)

No